Guardant Health (GH) Stock: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$162.94
-3.72 (-2.23%)
▼
5d:
-1.77%
30d:
-7.58%
90d:
+10.6%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: GH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $162.94, which is considered oversold relative to its 30-day fair value range of $163.86 to $178.87.
Technical Outlook: Technically, GH is in a strong uptrend. Immediate support is located at $155.00, while resistance sits at $171.22.
Market Sentiment: GH scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $201.64 (+23.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GH is in a strong uptrend. Immediate support is located at $155.00, while resistance sits at $171.22.
Market Sentiment: GH scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $201.64 (+23.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$163.86 -
$178.87
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (83/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.8% below Wall St target ($201.64)
- BULLISH: Bottoming setup score 83/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$163.86 -
$178.87
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$155.00
Resistance Level
$171.22
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-398.68
Wall Street Target
$201.64
(+23.8%)
Revenue Growth (YoY)
44.3%
Profit Margin
-38.3%
Share & Embed Analysis
Last updated: October 22, 2026 9:50 PM ET
Data refreshes hourly during market hours. Next update: 10:50 PM
Data refreshes hourly during market hours. Next update: 10:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 41 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 59 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 36 SELL |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
22 analysts |
$299 | 50 HOLD |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
